|
| 36538387 | Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma. | Arch Pathol Lab Med | 2023 |
| 37902951 | Attack of the clones: Unveiling subclonal/heterogenous mismatch repair (MMR)/microsatellite instability (MSI) status in endometrial cancer (EC). | | 2023 |
| 37634258 | Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women. | | 2023 |
| 37606287 | Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment. | | 2023 |
| 37527178 | Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins. | | 2023 |
| 37497483 | Enhanced 3D visualization of human fallopian tube morphology using a miniature optical coherence tomography catheter. | | 2023 |
| 37400526 | Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival. | Commun Biol | 2023 |
| 37330596 | Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor. | Oncogene | 2023 |
| 37272756 | Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21-CDK4/6-Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance. | Cancer Res | 2023 |
| 37159719 | Weakly Supervised Deep Learning for Predicting the Response to Hormonal Treatment of Women with Atypical Endometrial Hyperplasia: A Feasibility Study. | | 2023 |
| 37088136 | In Silico Approaches to Proficiency Testing: Considerations for Continued Feasibility. | J Mol Diagn | 2023 |
| 36916760 | Depth-resolved attenuation mapping of the human ovary and fallopian tube using optical coherence tomography. | | 2023 |
| 36609389 | A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN). | | 2023 |
| 36151126 | Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy. | Scientific Reports | 2022 |
| 36001024 | Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. | Cancer Discov | 2022 |
| 33040615 | Histopathology of Third Trimester Placenta from SARS-CoV-2-Positive Women. | Fetal and Pediatric Pathology | 2022 |
| 35067601 | Expression of Potential Biomarker Targets by Immunohistochemistry in Cervical Carcinomas. | International Journal of Gynecological Pathology | 2022 |
| 34922362 | Estimating the Breast Cancer Risk Conferred by Germline Mutations. | Clinical Chemistry | 2022 |
| 34670865 | GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress. | Molecular Cancer Research | 2022 |
| 36585404 | A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. | | 2022 |
| 34324625 | Advancing Fellowship Training in Selective Pathology. | | 2022 |
| 33757455 | In-laboratory breast specimen radiography reduces tissue block utilization and improves turnaround time of pathologic examination. | BMC Medical Imaging | 2021 |
| 33635941 | Pathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging. | | 2021 |
| 33423806 | The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women. | Gynecologic Oncology | 2021 |
| 33397681 | Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial. | Clin Cancer Res | 2021 |
| 33034056 | Identification of novel ALK rearrangements in gynecologic clear cell carcinoma. | International Journal of Cancer | 2021 |
| 34801874 | Prospective assessment of adjunctive ultrasound-guided diffuse optical tomography in women undergoing breast biopsy: Impact on BI-RADS assessments. | European Journal of Radiology | 2021 |
| 34454106 | Molecular Testing in Breast Cancer: Current Status and Future Directions. | Journal of Molecular Diagnostics | 2021 |
| 34173924 | Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer. | Breast Cancer Res Treat | 2021 |
| 34125170 | Retroperitoneal Dedifferentiated Liposarcoma. | American Journal of Clinical Pathology | 2021 |
| 33970392 | Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography. | Breast Cancer Research and Treatment | 2021 |
| 31816269 | Clinical Decision Support for Ovarian Carcinoma Subtype Classification: A Pilot Observer Study With Pathology Trainees. | | 2020 |
| 32964092 | Detection of a somatic <i>GREB1-NCOA1</i> gene fusion in a uterine tumor resembling ovarian sex cord tumor (UTROSCT). | Gynecol Oncol Rep | 2020 |
| 32665297 | Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial. | Clin Cancer Res | 2020 |
| 32628757 | Sequence Now, Later, or Never? | Clinical Chemistry | 2020 |
| 32353358 | Pathologic findings in fallopian tubes of women with chronic pelvic pain after Essure placement. | | 2020 |
| 31304678 | Histogram analysis of en face scattering coefficient map predicts malignancy in human ovarian tissue. | | 2019 |
| 30478151 | Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer. | Molecular Cancer Therapeutics | 2019 |
| 31865465 | Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer. | Medical Oncology | 2019 |
| 31586106 | Optical Resolution Photoacoustic Microscopy of Ovary and Fallopian Tube. | Scientific Reports | 2019 |
| 29084048 | Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair. | International Journal of Gynecological Pathology | 2018 |
| 28879586 | Multiple Myeloma Presenting as Massive Amyloid Deposition in a Parathyroid Gland Associated with Amyloid Goiter: A Medullary Thyroid Carcinoma Mimic on Intra-operative Frozen Section. | Head and Neck Pathology | 2018 |
| 30204078 | Evaluation of Ovarian Cancer: Initial Application of Coregistered Photoacoustic Tomography and US. | Radiology | 2018 |
| 29775456 | Maternal obesogenic diet induces endometrial hyperplasia, an early hallmark of endometrial cancer, in a diethylstilbestrol mouse model. | PLoS ONE | 2018 |
| 29761000 | Quantitative multispectral optical evaluation of human ovarian tissue using spatial frequency domain imaging. | Biomedical Optics Express | 2018 |
| 29570565 | p16 Immunohistochemistry Is Not Always Required For Accurate Diagnosis of Grade 2 Squamous Intraepithelial Lesions. | Journal of Lower Genital Tract Disease | 2018 |
| 29326971 | Cervical clear cell adenocarcinoma with an exceptionally low proliferation index: Report of a case. | Gynecologic Oncology Reports | 2018 |
| 29088745 | Increased breast tissue receptor activator of nuclear factor-κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women. | Oncotarget | 2017 |
| 28904132 | Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer. | Molecular Cancer Therapeutics | 2017 |
| 28874413 | A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer. | Clin Cancer Res | 2017 |